Cocrystal Pharma, Inc. (NASDAQ:COCP) Sees Significant Increase in Short Interest

Cocrystal Pharma, Inc. (NASDAQ:COCP) saw a large growth in short interest in December. As of December 31st, there was short interest totalling 27,900 shares, a growth of 59.4% from the December 15th total of 17,500 shares. Currently, 0.4% of the company’s stock are short sold. Based on an average daily volume of 42,300 shares, the short-interest ratio is presently 0.7 days.

Cocrystal Pharma Stock Performance

Shares of COCP traded down $0.03 during midday trading on Friday, hitting $1.98. The company had a trading volume of 21,025 shares, compared to its average volume of 45,302. The company’s 50-day simple moving average is $2.15 and its 200-day simple moving average is $2.00. Cocrystal Pharma has a 1 year low of $1.33 and a 1 year high of $3.26. The firm has a market capitalization of $20.14 million, a P/E ratio of -1.07 and a beta of 1.53.

Cocrystal Pharma Company Profile

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.